CM
ANIP icon

Caption Management’s ANI Pharmaceuticals ANIP Stock Holding History

Caption Management’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.31M Sell
40,000
-95,890
-71% -$7.69M 0.02% 724
2026
Q1 		$10.4M Buy
135,890
+78,117
+135% +$6.1M 0.06% 323
2025
Q4 		$4.56M Buy
+57,773
New +$5M 0.03% 550

Other funds holding ANIP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
GACM
Global Alpha Capital Management Montreal, Quebec, Canada $1.67B AUM 35.09% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Caption Management's ANIP Position: Q2 2026 in Review

Caption Management reduced its ANI Pharmaceuticals (ANIP) stake by 71% in Q2 2026, selling an estimated $7.69M and leaving 40,000 shares worth $3.31M. The position accounts for 0.02% of the portfolio, ranked #724.

Caption Management first reported a position in ANIP in Q4 2025 and has held it in 3 quarters since. The position peaked at $10.4M in Q1 2026. 307 funds tracked by Wall St. Rank hold ANIP as of Q2 2026.

  • Caption Management held 40,000 shares of ANI Pharmaceuticals worth $3.31M as of Q2 2026.
  • Caption Management sold 95,890 ANI Pharmaceuticals shares in Q2 2026, an estimated $7.69M.
  • ANI Pharmaceuticals made up 0.02% of Caption Management's portfolio in Q2 2026, its #724 holding.
  • Caption Management first reported a position in ANI Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • Caption Management's ANI Pharmaceuticals position peaked at $10.4M in Q1 2026.
  • 307 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q2 2026.

Based on Caption Management's 13F filing for Q2 2026, filed 14 Aug 2026.